J.M. Vannetzel

Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2

Stéphane Oudard, Stéphane Culine, Yann Vano et al. · European Journal of Cancer · 2014 · 144 citations

Medicine, Oncology, Pharmacology +14

Radiosurgery With or Without A 2-mm Margin for 93 Single Brain Metastases

F. Nataf, Michel Schlienger, Zhihua Liu et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 96 citations

Medicine, Neurosurgery, Surgery +14

Phase II Study of Oxaliplatin and Fluorouracil in Taxane- and Anthracycline-Pretreated Breast Cancer Patients

Laurent Zelek, Paul Cottu, M. Tubiana-Hulin et al. · Journal of Clinical Oncology · 2002 · 56 citations

Medicine, Oncology, Pharmacology +17

Five Years of Exemestane as Initial Therapy Compared to 5 Years of Tamoxifen Followed by Exemestane: The TEAM Trial, a Prospective, Randomized, Phase III Trial in Postmenopausal Women with Hormone-Sensitive Early Breast Cancer.

Daniel Rea, Annette Hasenburg, C. Seynaeve et al. · Cancer Research · 2009 · 44 citations

Medicine, Oncology, Pharmacology +17

Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patients

Jean‐Pierre Droz, Xavier Muracciole, Nicolas Mottet et al. · Annals of Oncology · 2003 · 38 citations · Full text

Medicine, Oncology, Pharmacology +16